Anti-Human Nanog FITC

Also known as: Homeobox protein NANOG, ES cell-associated protein 4, Early embryo specific expression NK-type homeobox protein, Homeobox transcription factor Nanog

Clone: hNanog.1

RUO: For Research Use Only. Not for use in diagnostic procedures.

Attention: Discontinued

SKU# 11-5769

Cat. No. Size
11-5769-41 25 tests
11-5769-71 25 tests

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human Nanog FITC.

Click on image to view more information.

More Views

  • Data for Anti-Human Nanog FITC.
Description

Description: The hNanog.1 antibody was generated against and reacts with human Nanog, a homeobox transcription factor. In addition to the known Oct4 and Stat3 transcriptional operating systems, Nanog plays a crucial role in the second embryonic cell fate specification following formation of the blastocyst. Nanog was identified as a gene specifically expressed in mouse ES cells and preimplantation embryos and is capable of maintaining ES cell self-renewal independently of LIF/Stat3. Potential cross-reactivity of this antibody to other proteins has not been determined.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate FITC
Laser Blue Laser
Emit 518 nm
Excite 488 nm
Reported Applications Intracellular Staining Followed by Flow Cytometric Analysis
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
13-5769 Anti-Human Nanog Biotin FC RUO
14-5769 Anti-Human Nanog Purified IHC, WB RUO
References

References: Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113(5):631-42.

Cavaleri F, Scholer HR. 2003. Nanog: a new recruit to the embryonic stem cell orchestra. Cell. 113(5):551-2

Hoei-Hansen CE, Kraggerud SM, et al. 2007. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer 2;6:12. (hNanog.1, IHC paraffin, PubMed)


View More Products

AntigensArea of BiologyCell TypeFormats